Treos Bio

Developer of cancer vaccines and companion diagnostics

placeLondon, England, United Kingdom calendar_todayFounded 2013 groups12 employees language treosbio.com

Registered entities

Social engagement

Social engagement: 753 social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

45 investors on record; lead investors include Luminous Ventures.

Investor typeCountShare
Venture capital511%
Private equity511%
Other / undisclosed3578%

Recent activity

28 May 2026
Leadership hire
Chief Executive Officer
1 Apr 2026
Partnership
TREOS BIO
23 Mar 2026
Event
Bio-Europe 2026
Coming soon